• Krasnianski A, Heinemann U, Ponto C, Kortt J, Kallenberg K, Varges D, Schulz-Schaeffer WJ, Kretzschmar HA, Zerr I. Clinical findings and diagnosis in genetic prion diseases in Germany. Eur J Epidemiol. 2015 Jun 16. [Epub ahead of print]
• Ramljak S, Schmitz M, Zafar S, Wrede A, Schenkel S, Asif AR, Carimalo J, Doeppner TR, Schulz-Schaeffer WJ, Weise J, Zerr I. Cellular prion protein directly interacts with and enhances lactate dehydrogenase expression under hypoxic conditions. Exp Neurol. 2015 May 27;271:155-167
• Schmitz M, Ebert E, Stoeck K, Karch A, Collins S, Calero M, Sklaviadis T, Laplanche JL, Golanska E, Baldeiras I, Satoh K, Sanchez-Valle R, Ladogana A, Skinningsrud A, Hammarin AL, Mitrova E, Llorens F, Kim YS, Green A, Zerr I. Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic. Mol Neurobiol. 2015 May 7. [Epub ahead of print]
• Krasnianski A, Bohling GT, Harden M, Zerr I. Psychiatric symptoms in patients with sporadic Creutzfeldt-Jakob disease in Germany. J Clin Psychiatry. 2015 Apr 14. [Epub ahead of print]
• Sanchez-Juan P, Bishop MT, Kovacs GG, Calero M, Aulchenko YS, Ladogana A, Boyd A, Lewis V, Ponto C, Calero O, Poleggi A, Carracedo Á, van der Lee SJ, Ströbel T, Rivadeneira F, Hofman A, Haïk S, Combarros O, Berciano J, Uitterlinden AG, Collins SJ, Budka H, Brandel JP, Laplanche JL, Pocchiari M, Zerr I, Knight RS, Will RG, van Duijn CM. A genome wide association study links glutamate receptor pathway to sporadic creutzfeldt-jakob disease risk. PLoS One. 2015 Apr 28;10(4):e0123654.
• Zafar S, Schmitz M, Younus N, Tahir W, Shafiq M, Llorens F, Ferrer I, Andéoletti O, Zerr I. Creutzfeldt-Jakob Disease Subtype-Specific Regional and Temporal Regulation of ADP Ribosylation Factor-1-Dependent Rho/MLC Pathway at Pre-Clinical Stage. J Mol Neurosci. 2015 Jun;56(2):329-48.
• Cramm M, Schmitz M, Karch A, Mitrova E, Kuhn F, Schroeder B, Raeber A, Varges D, Kim YS, Satoh K, Collins S, Zerr I. Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease. Mol Neurobiol. 2015 Apr 1. [Epub ahead of print]
• Karch A, Hermann P, Ponto C, Schmitz M, Arora A, Zafar S, Llorens F, Müller-Heine A, Zerr I. Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease. Neurobiol Aging. 2015 May;36(5):1964-8.
• Lukic A, Uphill J, Brown CA, Beck J, Poulter M, Campbell T, Adamson G, Hummerich H, Whitfield J, Ponto C, Zerr I, Lloyd SE, Collinge J, Mead S. Rare structural genetic variation in human prion diseases. Neurobiol Aging. 2015 May;36(5):2004
• Cramm M, Schmitz M, Karch A, Zafar S, Varges D, Mitrova E, Schroeder B, Raeber A, Kuhn F, Zerr I. Characteristic CSF Prion Seeding Efficiency in Humans with Prion Diseases.
• Mol Neurobiol. 2015;51:396-405.

• Löffler J, Krasemann S, Zerr I, Matschke J, Glatzel M. No reactivation of JCV and CMV infections in the temporal cortex and cerebellum of sporadic Creutzfeldt-Jakob disease patients. Am J Neurodegener Dis. 2014 Dec 5;3(3):152-7
• Schmitz M, Zafar S, Silva CJ, Zerr I. Behavioral abnormalities in prion protein knockout mice and the potential relevance of PrP(C) for the cytoskeleton. Prion. 2014;8(6):381-6.
• Stoeck K, Schmitz M, Ebert E, Schmidt C, Zerr I. Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer´s disease and multiple sclerosis. J Neuroinflammation 2014;11(1):170 http://www.jneuroinflammation.com/content/11/1/170
• Minikel EV, Zerr I, Collins SJ, Ponto C, Boyd A, Klug G, Karch A, Kenny J, Collinge J, Takada LT, Forner S, Fong JC, Mead S, Geschwind MD. Ascertainment bias causes false signal of anticipation in genetic prion diseases. Am J Hum Genet 2014;95(4):371-82.
• Hermann P, Romero C, Schmidt C, Reis C, Zerr I. CSF Biomarkers and Neuropsychological Profiles in Patients with Cerebral Small-Vessel Disease. PLoS One 2014;9(8):e105000
• Llorens F, López-González I, Thüne K, Carmona M, Zafar S, Andréoletti O, Zerr I, Ferrer I. Subtype and regional-specific neuroinflammation in sporadic Creutzfeldt-Jakob disease. Front Aging Neurosci 2014;6:198
• Llorens F, Zafar S, Ansoleaga B, Shafiq M, Blanco R, Carmona M, Grau-Rivera O, Nos C, Gelpí E, Del Río J, Zerr I, Ferrer I. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 2014;6:198
• Schmidt C, Gerlach N, Peter C, Gherib K, Lange K, Fride T, Zerr I. Cerebrospinal Fluid Apolipoprotein E Concentration and Progression of Alzheimer's Disease. J Alzheimers Dis 2014;21(10):1705-8
• Krasnianski A, Kaune J, Jung K, Kretzschmar HA, Zerr I. First symptom and initial diagnosis in sporadic CJD patients in Germany. J Neurol. 2014; 26(9):1811-7
• Slattery C, Beck J, Harper L, Adamson G, Abdi Z, Uphill J, Campbell T, Druyeh R, Mahoney C, Rohrer J, Kenny J, Lowe J, Leung K, Barnes J, Clegg S, Blair M, Nicholas J, Guerreiro R, Rowe J, Ponto C, Zerr I, Kretzschmar H, Gambetti P, Crutch S, Warren J, Rossor M, Fox N, Collinge J, Schott J, Mead S. R47H TERM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia. Alzheimers Dement. 2014;10:602-608.
• Schmidt C, Wolff M, von Ahsen N, Lange K, Friede T, Zerr I. CR1 is potentially associated with rate of decline in sporadic Alzheimer's disease. J Clin Neurosci. 2014;21:1705-8.
• Schmitz M, Greis C, Ottis P, Silva CJ, Schulz-Schaeffer WJ, Wrede A, Koppe K, Onisko B, Requena JR, Govindarajan N, Korth C, Fischer A, Zerr I. Loss of prion protein leads to age-dependent behavioral abnormalities and changes in cytoskeletal protein expression. Mol Neurobiol. 2014;50(3):923-36
• Karch A, Raddatz LM, Ponto C, Hermann P, Summers D, Zerr I. Diagnostic profiles of patients with late-onset Creutzfeldt-Jakob disease differ from those of younger Creutzfeldt-Jakob patients: a historical cohort study using data from the German National Reference Center. J Neurol. 2014;261(5):877-83
• Schmidt C, Becker H, Peter C, Lange K, Friede T, Zerr I. Plasma prion protein concentration and progression of Alzheimer disease. Prion. 2014;8(2).pii:27964
• Dohler F, Sepulveda-Falla D, Krasemann S, Altmeppen H, Schlüter H, Hildebrand D, Zerr I, Matschke J, Glatzel M. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease. Brain. 2014 Mar;137(Pt 3):873-86
• Haïk S, Marcon G, Mallet A, Tettamanti M, Welaratne A, Giaccone G, Azimi S, Pietrini V, Fabreguettes JR, Imperiale D, Cesaro P, Buffa C, Aucan C, Lucca U, Peckeu L, Suardi S, Tranchant C, Zerr I, Houillier C, Redaelli V, Vespignani H, Campanella A, Sellal F, Krasnianski A, Seilhean D, Heinemann U, Sedel F, Canovi M, Gobbi M, Di Fede G, Laplanche JL, Pocchiari M, Salmona M, Forloni G, Brandel JP, Tagliavini F. Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014 Feb;13(2):150-8
• Zafar S, Asif AR, Ramljak S, Tahir W, Schmitz, M, Zerr I. Anchorless 23-230 PrPc interacttomics for elucidation of PrPc protective role. Mol Neurobiol 2014;49(3):1385-99
• Douet JY, Zafar S, Perret-Liaudet A, Lacroux C, Lugan S, Aron N, Cassard H, Ponto C, Corbière F, Torres JM, Zerr I, Andreoletti O. Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease. Emerg Infect Dis 2014 Jan;20:114-7.
• Schmitz M, Lüllmann K, Zafar S, Ebert E, Wohlhage M, Oikonomou P, Schlomm M, Mitrova E, Beekes M, Zerr I. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic of familial prion diseases. Neurobiol Aging. 2014;35(5):177-88
• Schmidt C, Becker H, Zerr I. Cerebrospinal Fluid Apolipoprotein E concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer´s disease. Am Alzheimers Dis Other Demen 2014;29(1):54-60
• Krasnianski A, Sanchez-Juan P, Ponto C, Bartl M, Heinemann U, Varges D, Schulz-Schaeffer WJ, Kretschmar HA, Zerr I. A proposal of new diagnostic pathway for fatal familial insomnia. J Neurol Neurosurg Psych 2014;85(6):654-9
• Schmitz M, Wulf K, Signore SC, Schulz-Schaeffer WJ, Kermer P, Bähr M, Wouters FS, Zafar S. Zerr I. Impact of the Cellular Prion Protein on Amyloid-ß and 3PO-Tau Processing. J Alzheimers Dis. 2014 1;38:551-65.
• Kaerst L, Kuhlmann A, Wedekind D, Stoeck K, Lange P, Zerr I. Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with lewy bodies, Parkinson's disease and Alzheimer's disease. J Alzheimers Dis. 2014;38:63-73

• Karch A, Manthey H, Ponto C, Hermann P, Heinemann U, Schmidt C, Zerr I. Investigating the Association of ApoE Genotypes with Blood-Brain Barrier Dysfunction measured by cerebrospinal fluid-serum albumin ratio in a cohort of Patients with different types of dementia. PLoS One 2013 Dec 27;8:e84405
• Llorens F, Ansoleaga B, Garcia-Esparcia P, Zafar S, Grau-Rivera O, López-González I, Blanco R, Carmona M, Yagüe J, Nos C, Del Rio JA, Gelpí E, Zerr I, Ferrer I. PrP mRNA and protein expression in brain and PrPc in CSF in Creutzfeldt-Jakob disease MM1 and VV2. Prion 2013;7(5):383-93
• Klug GM, Wand H, Simpson M, Law M, Masters CL, Matej R, Howley R, Farrell M, Breithaupt M, Zerr I, van Duijn C, Ibrahim-Verbaas C, Mackenzie J, Will RG, Brandel JP, Alperovitch A, Budka H, Kovacs GG, Jansen GH, Coulthard M, Collins SJ. Intensity of human prion disease surveillance predicts observed disease incidence. J Neurol Neurosurg Psychiatry. 2013;84:1372-7
• Kaerst L, Kuhlmann A, Wedekind D, Stoeck K, Lange P, Zerr I. Cerebrospinal fluid biomarkers in Alzheimer's disease, vascular dementia and ischemic stroke patients: a critical analysis. J Neurol. 2013;260:2722-7
• Wemheuer WM, Wrede A, Gawinecka J, Zerr I, Schulz-Schaeffer WJ. Filtration of protein aggregates increases the accuracy for diagnosing prion diseases in brain biopsies. J Neuropathol Exp Neurol. 2013 Aug;72(8):758-67.
• Roettger Y, Zerr I, Dodel R, Bach JP. Prion peptide uptake in microglial cells--the effect of naturally occurring autoantibodies against prion protein.PLoS One. 2013 Jun 28;8(6):e67743.
• Goldeck D, Larbi A, Pellicanó M, Alam I, Zerr I, Schmidt C, Fulop T, Pawelec G. Enhanced chemokine receptor expression on leukocytes of patients with Alzheimer's Disease. PLoS One. 2013 Jun 18;8(6):e66664.
• Gawinecka J, Nowak M, Carimalo J, Cardone F, Asif AR, Wemheuer WM, Schulz-Schaeffer WJ, Pocchiari M, Zerr I. Subtype-Specific Synaptic Proteome Alterations in Sporadic Creutzfeldt-Jakob Disease. J Alzheimers Dis. 2013;37:51-61.
• Karch A, Zerr I. A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2013 May 28;80(22):2081.
• Zerr I. Human prion diseases: progress in clinical trials. Brain. 2013 Apr;136(Pt 4):996-7.
• Varges D, Schulz-Schaeffer WJ, Wemheuer WM, Damman I, Schmitz M, Cramm M, Kallenberg K, Shirneshan K, Elkenani M, Markwort S, Faist M, Kohlhase J, Windl O, Zerr I. Spongiform encephalopathy in siblings with no evidence of protease-resistant prion protein or a mutation in the prion protein gene. J Neurol. 2013;260(7):1871-9.
• Schelzke G, Stoeck K, Eigenbrod S, Grasbon-Frodl E, Raddatz LM, Ponto C, Kretzschmar HA, Zerr I. Report about four novel mutations in the prion protein gene. Dement Geriatr Cogn Disord. 2013;35(3-4):229-37.
• Schmidt C, Karch A, Artjomova S, Hoeschel M, Zerr I. Pre-progression rates in Alzheimer's disease revisited. J Alzheimers Dis. 2013 Jan 1;35(3):451-4.
• Schmidt C, Artjomova S, Hoeschel M, Zerr I. CSF prion protein concentration and cognition in patients with Alzheimer disease. Prion. 2013 May 1;7(3):229-34.
• Sano K, Satoh K, Atarashi R, Takashima H, Iwasaki Y, Yoshida M, Sanjo N, Murai H, Mizusawa H, Schmitz M, Zerr I, Kim YS, Nishida N. Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay. PLoS One. 2013;8(1):e54915.
• Dieks JK, Gawinecka J, Asif AR, Varges D, Gmitterova K, Streich JH, Dihazi H, Heinemann U, Zerr I. Low-abundant cerebrospinal fluid proteome alterations in dementia with lewy bodies. J Alzheimers Dis. 2013 Jan 1;34(2):387-97.
• Roettger Y, Du Y, Bacher M, Zerr I, Dodel R, Bach JP. Immunotherapy in prion disease. Nat Rev Neurol. 2013 Feb;9(2):98-105.
• Marek M, Klockgether T, Urbach H, Zerr I, Kretzschmar H, Paus S. Isolated spasticity in sporadic Creutzfeldt-Jakob disease. J Neurol. 2013 Feb;260(2):654-5. Schmitz M, Signore SC, Zerr I, Althaus HH. Oligodendroglial process formation is differentially affected by modulating the intra- and extracellular cholesterol content. J Mol Neurosci. 2013 Mar;49(3):457-69.
• Breithaupt M, Romero C, Kallenberg K, Begue C, Sanchez-Juan P, Eigenbrod S, Kretzschmar H, Schelzke G, Meichtry E, Taratuto A, Zerr I. Magnetic resonance imaging in E200K and V210I mutations of the prion protein gene. Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):87-90.

2012

• Gawinecka J, Cardone F, Asif AR, De Pascalis A, Wemheuer WM, Schulz-Schaeffer WJ, Pocchiari M, Zerr I. Proteomics. 2012 Dec;12(23-24):3610-20. Schmidt C, Karch A, Korth C, Zerr I. On the issue of transmissibility of Alzheimer disease: a critical review. Prion. 2012 Nov-Dec;6(5):447-52.
• Stoeck K, Sanchez-Juan P, Gawinecka J, Green A, Ladogana A, Pocchiari M, Sanchez-Valle R, Mitrova E, Sklaviadis T, Kulczycki J, Slivarichova D, Saiz A, Calero M, Knight R, Aguzzi A, Laplanche JL, Peoc'h K, Schelzke G, Karch A, van Duijn CM, Zerr I. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain. 2012 Oct;135(Pt 10):3051-61.
• Appleby BS, Zerr I. Sporadic Creutzfeldt-Jakob disease: changes not only in the brain? Neurology. 2012 Sep 4;79(10):965-6. Aug 1. No abstract available.
• Zilles D, Zerr I, Wedekind D. Successful treatment of musical hallucinations with the acetylcholinesterase inhibitor donepezil. J Clin Psychopharmacol. 2012 Jun;32(3):422-4.
• Alcalde-Cabero E, Almazan-Isla J, Brandel JP, Breithaupt M, Catarino J, Collins S, Hayback J, Hoftberger R, Kahana E, Kovacs GG, Ladogana A, Mitrova E, Molesworth A, Nakamura Y, Pocchiari M, Popovic M, Ruiz-Tovar M, Taratuto A, van Duijn C, Yamada M, Will RG, Zerr I, de Pedro Cuesta J. Health professions and risk of sporadic Creutzfeldt-Jakob disease, 1965 to 2010. Euro Surveill. 2012 Apr 12;17(15).
• Schmidt C, Haïk S, Satoh K, Rábano A, Martinez-Martin P, Roeber S, Brandel JP, Calero-Lara M, de Pedro-Cuesta J, Laplanche JL, Hauw JJ, Kretzschmar H, Zerr I. Rapidly progressive Alzheimer's disease: a multicenter update. J Alzheimers Dis. 2012;30(4):751-6.
• Schmidt C, Wolff M, von Ahsen N, Zerr I. Alzheimer's disease: genetic polymorphisms and rate of decline. Dement Geriatr Cogn Disord. 2012;33(2-3):84-9.
• Schelzke G, Kretzschmar HA, Zerr I. Clinical aspects of common genetic Creutzfeldt-Jakob disease. Eur J Epidemiol. 2012 Feb;27(2):147-9.
• Gawinecka J, Ciesielczyk B, Sanchez-Juan P, Schmitz M, Heinemann U, Zerr I. Desmoplaktin as a potential candidate for cerebrospinal fluid marker to rule out 14-3-3 false positive rates in sporadic Creutzfeldt-Jakob disease differential diagnosis. Neurodegener Dis, 2012;9(3):139-44
• Sanchez-Juan P, Bishop MT, Aulchenko YS, Brandel JP, Rivadeneira F, Struchalin M, Lambert JC, Amouyel P, Combarros O, Sainz J, Carracedo A, Uitterlinden AG, Hofman A, Zerr I, Kretzschmar HA, Laplanche JL, Knight RS, Will RG, van Duijn CM. Genome-wide study links MTMR7 gene to variat Creutzfeldt-Jakob risk. Neurobiol Aging, 2012;33(7):1487 e.21-8

2011

• Gabelic T, Habek M, Zerr I, Gawinecka J, Pavlisa G, Brinar VV. Sporadic CJD in a patient with relapsing-remitting multiple sclerosis on an immunomodulatory treatment. Acta Neurol Belg, 2011;111:232-6.
• Kim HL, Do JY, Cho HJ, Jeon YC, Park SJ, Ma HI, Song JH, Lee Y, Choi H, Choi KC, Kim YS, Zerr I, Kallenberg K, Kim YJ. Dura mater graft-associated Creutzfeldt-Jakob disease: the first case in Korea. J Korean Med Sci, 2011; 26:1515-7
• Schmidt, C., Wolff, M., Weitz, M., Bartlau, T., Korth, C., Zerr, I. Rapidly progressive Alzheimer disease. Arch Neurol, 2011; 68:1124-30
• Zafar, S., von Ahsen, N., Oellerich, M., Zerr, I., Schulz-Schaeffer, WJ., Armstrong, VW., Asif, AR. Proteomics Approach to identify the interacting partners of cellular prion protein and characterization of Rab7a interaction in neuronal cells. J Proteome Res, 2011; 10:3123-35
• Schmitz, M., Zerr, I., Althaus, HH. Effect of cavtratin, a caveolin-1 scaffolding domain peptide, on oligodendroglial signaling cascades. Cell Mol Neurobiol, 2011;31(7):991-7
• Eigenbrod, S., Frick, P., Giese, A., Schelzke, G., Zerr, I. Kretzschmar, HA. Comprehensive neuropathologic analysis of genetic prion disease associated with the E196K mutation in PRNP reveals phenotypic heterogeneity. J Neuropathol Exp Neurol, 2011;70:192-200.
• Schelzke, G., Eigenbrod, S., Romero, C., Varges, D., Breithaupt, M., Taratuto, AL., Kretzschmar, HA., Zerr, I. Genetic prion disease with codon 196 PRNP mutation: clinical and pathological findings. Neurobiol Aging, 2011;32:756. e1-9
• Stoeck, K., Zerr, I. Cellular immune activation markers neopterin and beta 2-microglobulin are not elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neuroimmunol, 2011;233:228-32.
• Kiesel, P., Gibson, TJ., Ciesielczyk, B., Bodemer, M., Kaup, FJ., Bodemer, W., Zischler, H., Zerr, I. Possible editing of Alu transcripts in blood cells of sporadic Creutzfeldt-Jakob disease (sCJD). J Toxicol Environ Health A, 2011;74:88-95.
• Varges D, Jung K, Gawinecka J, Heinemann U, Schmitz M, von Ahsen N, Krasnianski A, Armstrong VW, Zerr I. Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease. J Alzheimers Dis. 2011;23:717-26.

2010

• Gawinecka, J., Dieks, J., Asif, A.R., Carimalo, J., Heinemann, U., Streich, J.H. Dihazi, H., Schulz-Schaeffer, W., Zerr, I. Codon 129 polymorphism specific cerebrospinal fluid proteome pattern in sporadic Creutzfeldt-Jakob disease and the implication of glycolytic enzymes in prion-induced pathology. J Proteome Res, 2010;9:5646-57
• Weiss, E., Ramljak, S., Asif, A., Ciesielczyk, B., Schulz-Schaeffer, W., Behrens, Chr., Zerr, I. Cellular prion protein (PrPc) overexpression disturbs cellular homeostasis in SH-SY5Y neuroblastoma cells but does not alter p53expression: a proteomic study. Neuroscience, 2010;169:1640-50
• Schmitz, M., Schlomm, M., Hasan, B., Beekes, M., Mitrova, E., Korth, C., Breil, A., Carimalo, J., Gawinecka, J., Varges, D., Zerr I. Codon 129 polymorphism and the E200K mutation do not affect the PrPc isoform composition in the cerebrospinal fluid from Creutzfeldt-Jakob disease patients. Eur J Neurosci, 2010;31:2024-31
• Martins-de-Souza, D., Wobrock, T., Zerr, I., Schmitt, A., Gawinecka, J., Falkai, P., Turck, Chr. Different apolipoprotein E and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenics and controls. World J Biol Psychiatry, 2010;11:719-28
• Martins-de-Souza, D., Maccarrone, G., Wobrock, T., Zerr, I., Gormanns, Ph., Reckow, S., Lebar, M., Falkai, P., Schmitt, A., Turck, Chr. Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers for schizophrenia. J Psychiatr Res, 2010;44:1176-89
• Kiesel, P., Gibson, TJ., Ciesielczyk, B., Bodemer, M., Kaup, FJ., Bodemer, W., Zischler, H., Zerr, I. Transcriptin of Alu DNA elements in blood cells of sporadic Creutzfeldt-Jakob disease (sCJD). Prion, 2010;4:87-93
• Schmidt, C., Redyk, K., Meissner, B., Krack, L., v Ahsen, N., Roeber, S., Kretzschmar, H., Zerr, I. Clinical features of rapidly progressive Alzheimer' disease. Dement Geriatr Cogn Disord, 2010;29:371-378
• Schmidt, C., Plickert, S., Summers, D., Zerr, I. Pulvinar Sign in Warnicke's Encephalopathy. CNS Spectr, 2010;15:215-8
• Knöferle, J., Ramljak, S., Koch, JC., Tönges, L., Asif, AR., Michel, U., Wouters, FS., Heermann, S., Krieglstein, K., Zerr, I., Bähr, M., Lingor, P. TGF-beta enhances neurite outgrowth via regulation of proteasome function and EFABP. Neurobiol Dis, 2010;38:395-404
• Schmitz, M., Klöppner, S., Klopfleisch, S., Möbius, W., Schwartz, P., Zerr, I. Althaus, H. H. Mutual effects of caveolin and nerve growth factor signaling in pig oligodendrocytes. J Neurosci Res, 2010;88:572-88

2009

• Gmitterová, K., Heinemann, U., Gawinecka, J., Varges, D., Ciesielczyk, B., Valkovic, P., Benetin, J., Zerr, I. 8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases. Neurodegener Dis, 2009;6:263-9
• Wemheuer, W. M., Benestad, S. L., Wrede, A., Schulze-Sturm, U., Wemheuer, W. E., Hahmann, U., Gawinecka, J., Schütz, E., Zerr, I., Brenig, B., Bratberg, B., Andréoletti, O., Schulz-Schaeffer, W. J. Similarities between forms of sheep scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion types. Am J Pathol, 2009;175:2566-73
• Zerr, I., Kallenberg, K., Summers, D. M., Romero, C., Taratuto, A., Heinemann, U., Breithaupt, M., Varges, D., Meissner, B., Ladogana, A., Schuur, M., Haik, S., Collins, S. J., Jansen, G. H., Stokin, G. B., Pimentel, J., Hewer, E., Collie, D., Smith, P., Roberts, H., Brandel, J. P., van Dujin, C., Pocchiari, M., Begue, C., Cras, P., Will, R. G., Sanchez-Juan, P. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain, 2009;132:2659-68.
• Parchi, P., Strammiello, R., Notari, S., Giese, A., Langeveld, J. P., Ladogana, A., Zerr, I., Roncaroli, F., Cras, P., Ghetti, B., Pocchiari, M., Kretzschmar, H., Capellari, S. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrP(Sc) types: an updated classification. Acta Neuropahol, 2009;118:659-71
• Meissner, B., Kallenberg, K., Sanchez-Juan, P., Collie, D., Summers, DM., Almonti, S., Collins, SJ., Smith, P., Cras, P., Janses, GH., Brandel JP, Coulthard, MB., Roberts, H., van Everbroeck, B., Galanaud, D., Mellina, V., Will, RG., Zerr, I. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology, 2009;72(23):1994-2001
• Kovacs, G., Sanchez-Juan, P., Ströbel, T., Schuur, M., Poleggi, A., Nocentini, S., Giannattasio, C., Belay, G., Bishop, M., Capellari, S., Parchi, P., Gelpi, E., Gal, A., Bakos, A., Molnar, M., Heinemann, U., Zerr, I., Knight, R., Mitrova, E, van Duijn, C., Budka, H. Cathepsin D (C224T) polymorphism in sporadic and genetic Creutzfeldt-Jakob disease. Alzheimer Dis Assoc Disord 2010;24:104-7
• Kittner, C., Heinemann, U., Zerr, I. Risk factors for sporadic Creutzfeldt-Jakob disease. Dtsch Med Wochenschr 2009;134(27):1429-35.
• Meyne, F., Gloeckner, S., Ciesielczyk, B., Hienemann, U., Krasnianski, A., Meissner, B., Zerr, I. Total prion protein levels in the cerebrospinal fluid in patients with various neurodegenerative disorders. J Alz Dis, 2009;17:863-73
• Ladogana, A., Sanchez-Juan, P., Mitrová, E., Green, A., Cuadrado-Corrales, N., Sánchez-Valle, R., Koscova, S., Aguzzi, A., Sklaviadis, T., Kulczycki, J., Gawinecka, J., Saiz, A., Calero, M., van Duijn, CM., Pocchiari, M., Knight, R., Zerr, I. J Neurol, 2009;256:1620-8 Epub
• Albrecht, P., Schmitz, M., Otto, M., Hemmer, B., Zerr, I., Hartung, H. P., Methner, A. Free caspase activity in CSF of patients with dementia. J Neurol, 2009;256:1561-2 Epub
• Meissner, B., Kallenberg, K., Ramljak, S., Krasnianski, A., Heinemann, U., Krebs, B., Budka, H., Barcic, A., Kretzschmar, H.A., Knauth, M., Schulz-Schaeffer, W.J., Zerr I. MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease. J Neurology, 2009;256:355-63 Epub
• Edler, J., Mollenhauer, B., Heinemann, U., Varges, D., Werner, C., Zerr, I., Schulz-Schaeffer, WJ. Movement disturbances in the differential diagnosis of Creutzfeldt-Jakob disease. Mov Dis, 2009 15; 24 (3):350-356

2008

• Miele, G., Seeger, H., Marino, D., Eberhard, R, Haikenwalder, M., Stoeck, K., Basagni, M., Knight, R., Green, A., Chiani, F., Wüthrich, RP., Hock, C., Zerr, I., Aguzzi, A. Urinary alpha1-antichymotrypsin: a biomarker of prion infection. PLoS ONE. 2008; 3(12):e 3870 Epub 2008 Dec 5.
• Weise J, Doeppner TR, Müller T, Wrede A, Schulz-Schaeffer W, Zerr I, Witte OW, Bähr M. Overexpression of cellular prion protein alters postischemic Erk1/2 phosphorylation but not Akt phosphorylation and protects against focal cerebral ischemia. Restor Neurol Neurosci. 2008;26(1):57-64
• Roeber, S., Grasbon-Frodl, EM, Windl, O., Krebs, B., Xiang, W., Vollmert, C., Illig, T., Schröter, A., Arzberger, T., Weber, P., Zerr, I., Kretzschmar, HA. Evidence for a pathogenic role of different mutations at codon 188 of PRNP. PLoS ONE 2008 ;3(5):e2147
• Krasnianski, A., Kallenberg, K., Collie, D.A., Meissner, B., Schulz-Schaeffer, W.J., Heinemann, U., Summers, D.M., Kretzschmar, H.A., Will, R.G., Zerr, I. MRI in the classical MM1 and the atypical MV2 subtype of sporadic CJD: an inter-observer agreement study. 2008, Eur J Neurology, 2008, 15: 762-771
• Ramljak, S., Asif, AR, Armstrong VW, Wrede A, Groschup, M, Buschmann, A, Schulz-Schaeffer, W, Bodemer, W. Zerr, I. Physiological role of the cellular prion protein (PrPc): protein profiling study in two cell culture systems. Journal of Proteome Research, 2008, 7(7): 2681-95
• Krasnianski, A., Bartl, M., Sanchez Juan, PJ., Heinemann, U., Meissner, B., Varges, D., Schulze-Sturm, U., Schulz-Schaeffer, WJ, Kretzschmar, HA, I. Zerr, I. Fatal familial insomnia: clinical features and early identification. Annals of Neurology, 2008; 63(5):658-61
• Gloeckner, S.F., Meyne, F., Wagner, F., Heinemann, U., Krasnianski, A., Meissner, B., Zerr, I. Transthyretin, tau and ß-Amyloid in clinical differential diagnosis of dementia. J Alz Dis, 2008, 14: 17-25
• Gmitterová , K., Heinemann, U., Bodemer, M., Krasnianski , A., Meissner, B., Kretzschmar, HA., Zerr , I.14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes Neurobiol Aging, 2008, Mar 5 (Epub ahead of print)
• Krasnianski, A., von Ahsen, N., Heinemann, U., Meissner, B., Kretzschmar, HA., Armstrong, V., Zerr, I. ApoE distribution and family history in genetic prion diseases in Germany. Journal Mol Neurosci, 2008; 34(1):45-50
• Rodríguez-Martínez A, Alfonso-Sánchez M, Peña, J, Zarranz J., Calero, M., Capellari, S., Sánchez-Valle, R., Zerr, I., de Pancorbo, M. Molecular evidence of founder effects of Fatal Familial Insomnia through SNP haplotypes around the D178N mutation. Neurogenetics, 2008, 9:109-118
• Heinemann, U., Krasnianski, A., Meissner, B., Kallenberg, K., Schulz-Schaeffer, W. J., Zerr, I. Brain biopsy in patients with suspected Creutzfeldt-Jakob disease. J Neurosurg, 2008; 109(4): 735-41
• Dabaghian, R., Zerr, I., Zanusso, G., Heinemann, U., Clewley, J. Detection of Proteinase K resistant proteins in the urine of patients with Creutzfeldt-Jakob and other neurodegenerative diseases. Prion, 2008 2(4):170-8
• Heinemann, U., Krasnianski, A., Meissner, B., Grasbon-Frodl, E., Kretzschmar, H.A., Zerr I. Novel PRNP mutation in a patient with a slow progressive dementia syndrome. Med Sci Monitor, 2008; 14(5): CS41-43
• Meissner, B., Kallenberg, K., Sanchez-Juan, P., Krasnianski, A., Heinemann, U., Varges, D., Knauth, M., Zerr ,I. Isolated cortical signal increase on the MRI as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. Am J Neurorad 2008, 29:1519-24
• Friedrich, M., Körte, R., Portero, C., Arzberger, T., Kretszchmar, HA, Zerr, I., Nacimiento, W. Fatal Familial Insomnia-a rare differential diagnosis in dementia. Fortsch Neurol Psychiatr 2008, 76 (1):36-40

2007

• Zuber, Ch., Miteregger, G., Pace, C., Zerr, I., Kretzschmar, HA, Weiss, S. Anti-LRP/LR-Antibody W3 hampers peripheral PrPSc propagation in Scrapie infected mice. Prion, 2007 Jul; 1(3):207-12
• Krebs, B., Bader, B., Klehmet, J., Grasbon-Frodl, E., Oertel, WH., Zerr, I., Stricker, S., Zschenderlein, R., Kretszchmar HA. A novel subtype of Creutzfeldt-Jakob disease characterized by a small 6 kDa PrP fragment. Acta Neuropathol (Berl) 2007; 114(2):195-9
• Krasnianski, A., von Ahsen, N., Heinemann, U., Meissner, B., Schulz-Schaeffer, W.J., Kretzschmar, H.A., Armstrong, V.W., Zerr, I. Increased frequency of positive family history of dementia in sporadic CJD. Neurobiol Aging, 2009;30:615-621
• Beekes, M., Zerr, I., Groschup M., Prion Research: Past, Present and Future. Veterinary Microbilogy Vet Microbiol 2007; 123: 285-286
• Heinemann, U., Krasnianski, A., Meissner, B., Kretzschamar, H. A., Zerr, I. Molecular subtype-specific clinical diagnosis of prion disease. Vet Microbiol 2007; 123 (4): 328-335
• Tschampa, H. J., Kallenberg, K., Meissner, B.,Kretzschmar, H. A., Knauth, M., Urbach, H. Zerr, I. Pattern of cortical changes in sporadic Creutzfeldt-Jakob diseasee. Am J Neurorad; 2007; 28(6): 1114-8
• Heinemann, U., Krasnianski, A., Meissner, B., Varges, D., Bartl, M., Stoeck, K., Kallenberg, K., Schulz-Schaeffer, W.J., Steinhoff, B.J., Kretzschmar, H.A., Zerr, I. Creutzfeldt-Jakob disease in Germany: a prospective 12-years surveillance. Brain 2007; 1330 (5): 1350-9
• Green, A., Sanchez-Juan, P., Ladogana, A., Cuadrado-Corrales, N., Sánchez-Valle, R., Mitrová, E., Stoeck, K., Sklaviadis, T., Kulczycki, J., Heinemann, U., Hess, K., Slivarichová, D., Saiz, A., Calero, M., Ingrosso, L., Knight, R., van Duijn, C., Zerr, I. CSF analysis in patients with sporadic CJD and other transmissible spongifom encephalopathies. Eur J Neurology 2007, 14: 121-124
• Dietz, K., Raddatz, G., Wallis, J., Müller, N., Zerr, I., Duerr, H-P., Lefévre, Seifried, E., Löwer, J. Blood transfusion and spread of variant Creutzfeldt-Jakob disease. Emerg Infect Dis; 2007 Jan; 13(1):89-96
• Sanchez-Juan, P., Sánchez-Valle, R., Green, Ladogana, A., Cuadrado-Corrales, N., Mitrová, E., Stoeck, K., Sklaviadis, T., Kulczycki, J., Hess, K., Krasnianski, A., Equestre, M., Slivarichová , D., Saiz, A., Calero, M., Pocchiari, M., Knight, R., van Duijn, CM., Zerr, I. Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurology, 2007, 254(7):901-6
• Tschampa, H. J., Zerr, I., Urbach, H. Radiological assessment of Creutzfeldt-Jakob disease. Eur Radiol 2007,17 (5):1200-11

2006

• de Pedro-Cuesta, J., Glatzel, M., Almazan, J., Stoeck, K., Mellina, V., Puopolo, M., Pocchiari, M., Zerr, I., Kretzschmar, HA, Brandel, JP., Delasnerie-Laupretre, N., Alperovitch, A., van Duijn, C., Sanchez-Juan, P., Collins, S., Lewis, V., Jansen, GH., Coulthart, MB., Gelpi, E., Budka H., Mitrova, E. Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002. BMC Public Health, 2006, 6: 278
• Krasnianski, A., Schulz-Schaeffer, W. J., Kallenberg, K., Meißner, B., Collie, D. A., Roeber, S., Bartl, M. Heinemann, U., Varges, D., Kretzschmar, H. A., Zerr, I. Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD. Brain 2006;129:2288-96.
• Sanchez-Juan, P., Green, A., Ladogana, A., Cuadrado-Corrales, N., Sánchez-Valle, R., Mitrova, E., Stoeck, K., Sklaviadis, T., Kulczycki, J., Hess, K., Bodemer, M., Slivarichová, D., Saiz, A., Calero, M., Ingrosso, L., Knight, R., Janssens, A. C. J. W. van Duijn, C. Zerr, I. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006;67 (4):637-43
• Kallenberg, K., Schulz-Schaeffer, W. J., Jastrow, U., Poser, S. Meissner, B., Tschampa, H. J., Zerr, I., Knauth, M. MR imaging of Creutzfeldt-Jakob disease (CJD): Comparative analysis of MR sequences. Am J Neuroradiol 2006;27(7):1459-62.
• Vollmert, C., Windl, O., Xiang, W., Rosenberger, A., Zerr, I., Wichmann, H. E., Bickeböller, H., Illig, T., Kretzschmar, H. A. and the KORA group. Significant association of a M129V independent polymorphism in the 5’ UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case control study. J Med Genet 2006;43(10):e53.
• Geldermann, H., Bartenschlager, H., Preuss, S., Melchinger-Wild, E., Herzog, K., Zerr, I. Polymorphic microsatellite sites in the PRNP region point to excess of homozygotes in Creutzfeldt-Jakob disease patients. Gene 2006;382:66-70
• Collins, S. J., Sanchez-Juan, P., Masters, C. M. L., Klug, G. M., van Duijn, C., Poleggi, A., Pocchiari, M., Almonti, S., Cuadrado-Corrales, N., de Pedro-Cuesta, J., Budka, H., Gelpi, E., Glatzel, M., Tolnay, M., Hewer, E., Zerr, I., Heinemann, U., Kretzschmar, H. A., Jansen, G. H., Olsen, E., Mitrova, E., Alpérovitch, A., Brandel, J-P., Mackenzie, J., Murray, K., Will, R. G. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic CJD. Brain 2006; 129:2278-87
• Boesenberg, C., Schulz-Schaeffer, W. J., Bodemer, M, Ciesielczyck, B., Meissner, B.,Krasnianski, A., Bartl, M., Heinemann, U., Varges, D., Eigenbrod, S., Kretzschmar, H. A., Green, A., Zerr, I. Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD? BMC Neurology 2006; 6:35
• Weise, J., Sandau, R., Schwarting, S., Crome, O., Wrede, A., Schulz-Schaeffer, W., Zerr, I. Bähr, M. Deletion of Cellular Prion Protein Results in Reduced Akt Activation, Enhanced Postischemic Caspase-3 Activation, and Exacerbation of Ischemic Brain Injury. Stroke 2006;37(5):1296-300.
• Krasnianski, A., Meissner, B., Schulz-Schaeffer, W. J., Kallenberg, K., Bartl, M., Heinemann, U., Varges, D., Kretzschmar, H. A., Zerr, I. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2006;63(6):876-80.
• Stoeck, K., Bodemer, M., Zerr, I. Pro- and antiinflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease. J Neuroimmunol 2006;172:175-81

2005

• Meissner, B., Westner, I. M., Kallenberg, K., Krasnianski, A., Bartl, M., Varges, D., Bösenberg, C., Kretzschmar, H. A., Knauth, M., Schulz-Schaeffer, W. J., Zerr, I. Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology 2005; 65: 1544-50.
• Xiang, W., Windl, O., Westner, I. M., Neumann, M., Zerr, I., Lederer, R. M., Kretzschmar, H. A. Cerebral gene expression profiles in sporadic Creutzfeldt-Jakob disease. Ann Neurol 2005; 58: 242-57.
• Boesenberg, C., Schulz-Schaeffer, W., Meissner, B., Kallenberg, K., Bartl, M., Heinemann, U., Krasnianski, A., Stoeck, K., Varges, D., Windl, O., Kretzschmar, H. A., Zerr, I. Clinical course in young sporadic CJD patients. Ann Neurol 2005; 58: 533-543.
• Stoeck, K., Bodemer, M., Ciesielczyk, B., Meissner, B., Bartl, M., Heinemann, U., Zerr, I. Interleukin 4 and Interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Arch Neurol 2005; 62: 1591-4.
• Kovacs, G. G., Puopolo, M., Ladogana, A., Pocchiari, M., Budka, H., van Duijn, C., Collins, S. J., Boyd, A., Giulivi, A., Coulthart, M., Delasnerie-Laupretre, N., Brandel, J. P., Zerr, I., Kretzschmar, H. A., de Pedro-Cuesta, J., Calero-Lara, M., Glatzel, M., Aguzzi, A., Bishop, M., Knight, R., Belay, G., Will, R., Mitrova, E. Genetic prion disease: the EUROCJD experience. Hum Genet 2005; 118 (2): 166-74.
• Tschampa, H., Kallenberg, K., Urbach, H., Meissner, B., Nicolay, C., Kretzschmar, H. A., Knauth, M., Zerr, I. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain 2005; 128: 2026-33.
• Jacobi, C., Arlt, S., Reiber, H., Westner, I., Kretzschmar, H. A., Poser, S., Zerr, I. Immunoglobulins and virus-specific antibodies in patients with Creutzfeldt-Jakob disease. Acta Neurol Scand 2005; 111: 185-190.
• Cepek, L., Steinacker, P., Mollenhauer, B., Wiese, B., Ciesielczyk, B. Bibl, M., Wiltfang, J., Zerr, I., Schulz-Schaeffer, W., Kretzschmar, H. A., Poser, S., Otto, M. Follow-up investigations of tau protein and S-100b levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 2005; 19: 376-382.
• Ladogana, A., Puopolo, M., Croes, E. A., Budka, H., Jarius, C., Collins, S., Klug, G. M., Sutcliffe, T., Giulivi, A., Alperovitch, A., Delasnerie-Laupretre, N., Brandel, J.-P., Poser, S., Kretzschmar, H., Rietveld, I., Mitrova, E., de Pedro-Cuesta, J., Martinez-Martin, P., Glatzel, M., Aguzzi, A., Knight, R., Ward, H., Pocchiari, M., van Duijn, C. M., Will, R. G., Zerr, I. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005; 64: 1586-1591.
• Bleich, S., Otto, M., Zerr, I., Kropp, S., Kretzschmar, H. A., Wiltfang, J. Creutzfeldt-Jakob disease and homocysteine levels in plasma and cerebrospinal fluid. Gerontology 2005; 51: 142-144.
• Krebs, B., Lederer, R.-M., Windl, O., Grasbon-Frodl, E.-M., Zerr, I., Kretzschmar, H. A. Creutzfeldt-Jakob disease associated with an R148H mutation of the prion protein gene. Neurogenetics 2005; 6: 97-100.
• Roeber, S., Krebs, B., Neumann, M., Windl, O., Zerr, I., Grasbon-Frodl, E. M., Kretzschmar, H. A. Creutzfeldt-Jakob disease in a patient with an R208H mutation of the prion protein gene (PRNP) and a 17-kDa prion protein fragment. Acta Neuropathol (Berl.) 2005; 109(4): 443-8.

2004

• Grasbon-Frodl, E., Schmalzbauer, R., Weber, P., Krebs, B., Windl, O., Zerr, I., Kretzschmar, H. A. A novel three extra-repeat insertion in the prion protein gene (PRNP) in a patient with Creutzfeldt-Jakob disease. Neurogenetics 2004; 4:249-50.
• Zerr, I., Bodemer, M., Poser, S., Kaboth, U., Oellerich, M., Armstrong, V. W. Plasminogen activities and concentrations in patients with sporadic Creutzfeldt-Jakob disease. Neuroscience Letters 2004; 371: 163-166.
• Weise, J., Sandau, R., Crone, O., Baehr, M., Zerr, I. Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neuroscience Letters 2004; 372: 146-50.
• Pocchiari, M., Puopolo, M., Croes, EA., Budka, H., Gelpi, E., Collins, S., Lewis, V., Sutcliffe, T., Guilivi, A., Delasnerie-Laupretre, N., Brandel, JP., Alperovitch, A., Zerr, I., Poser, S., Kretzschmar, HA., Ladogana, A., Rietvald, I., Mitrova, E., Martinez-Martin, P. De Pedro-Cuesta, J., Glatzel, M., Aguzzi, A., Cooper, S., Mackenzie, J., Van Duijn, CM., Will, RG. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 2004; 127: 2348-59.
• Meissner, B., Köhler, K., Körtner, K., Bartl, M., Jastrow, U., Mollenhauer, B., Schröter, A., Finkenstaedt, M., Windl, O., Poser S., Kretzschmar, H.A., Zerr, I. Sporadic Creutzfeldt-Jakob disease: Magnetic resonance imaging and clinical findings. Neurology 2004; 63: 450-56.
• Steinhoff, J. B., Zerr, I., Glatting, M., Schulz-Schaeffer, W., Kretzschmar, H. A., Poser, S. The diagnostic value of periodic sharp wave complexes in the diagnosis of sporadic Creutzfeldt-Jakob disease - a study in 150 autoptically verified versus 56 autoptically excluded cases. Ann Neurol 2004; 56: 1-6

2003

• Kretzschmar, H. A., Sethi, S., Földvári, Z., Windl, O., Querner, V., Zerr I., Poser, S. Iatrogenic Creutzfeldt-Jakob disease with florid plaques. Brain Pathology 2003; 13: 245-249.
• Wiltfang, J., Esselmann, H., Smirnov, A., Bibl, M., Cepek, L., Steinacker, P., Mollenhauer, B., Buerger, K., Hampel, H., Paul, S., Neumann, M., Maler, M., Zerr, I., Kornhuber, J., Kretzschmar, H. A., Poser, S., Otto, M. Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Ann Neurol 2003; 54(2): 263-267
• Mollenhauer, B., Serafin, S., Zerr, I., Steinhoff, B. J., Otto, M., Scherer, M., Schulz-Schaeffer, W. J., Poser, S. Diagnostic problems during late course in Creutzfeldt-Jakob disease. J Neurol 2003; 250: 629-630.

2002

• Ward H. J. T., Everington D., Croes E. A., Alpérovitch A., Delasnerie-Lauprêtre N., Zerr I., Poser, S., van Duijn, C. M. (for the European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD)). Sporadic Creutzfeldt-Jakob disease and surgery - a case control study using community controls. Neurology 2002; 59: 543-548.
• Tschampa, H. J., Herms, J. W., Schulz-Schaeffer, W. J., Maruschak, B., Windl, O., Jastrow, U., Zerr, I., Steinhoff, B. J., Poser, S., Kretzschmar, H. A. Clinical findings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathology. Brain 2002;125:2558-2566
• Henkel, K., Zerr, I., Hertel, A., Gratz, K.-F., Schröter, A., Tschampa, H. J., Bihl, H., Büll, U., Grünwald, F., Drzezga, A., Spitz, J., Poser, Poser, S. Positron emission tomography with [18F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD). J Neurol 2002; 249: 699-705
• Arlt, S., Kontush, A., Zerr, I., Buhmann, C., Jacobi, C., Schröter, A., Poser, S., Beisiegel, U. Increased lipid peroxidation in cerebrospinal fluid and plasma from patients with Creutzfeldt-Jakob disease. Neurobiol Dis 2002; 10: 150-156
• Mollenhauer, B., Zerr, I., Ruge, D., Krause, G., Mehnert, W. H., Kretzschmar, H. A., Poser, S. Epidemiology and clinical symptomatology of Creutzfeldt-Jakob disease. DMW 2002; 127(7): 312-317

2001

• Schröder, B., Franz, B., Hempfling, P., Selbert, M., Jürgens, T., Kretzschmar, H. A., Bodemer, M., Poser, S., Zerr, I. Polymorphisms within the prion-like protein gene (Prnd) and their implications in human prion diseases, Alzheimer's disease and other neurological disorders. Hum Genet 2001; 109:319-325
• Völkel, D., Zimmermann, K., Zerr, I., Lindner, T., Bodemer, M., Poser, S., Schwarz, H.P. C-reactive protein and IL-6: new marker proteins for the diagnosis of CJD in plasma? Transfusion 2001; 41:1509-1514
• The EUROCJD Group, Writing Committee: Alpérovitch, A., Zerr, I., Windl, O., Poser, S., Pocchiari, P., van Duijn, C. M., Mitrova, E., Will, R. G. Genetic epidemiology of Creutzfeldt-Jakob disease in Europe. Rev Neurol (Paris) 2001; 157:633-637
• Tschampa, H.J., Neumann, M., Zerr, I., Henkel, K., Schröter, A., Schulz-Schaeffer, W.J., Steinhoff, B.J., Kretzschmar, H.A., Poser, S. Patients with Alzheimer disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001; 71: 33-39
• Zerr, I. Clinical diagnostic tests in human prion diseases. Arch Ins Neurol 2001; 1:45-48
• Völkel, D., Zimmermann, K., Zerr, I., Bodemer, M., Poser, S., Lindner, T., Turecek, P.L., Schwarz, H.P. Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases. Transfusion 2001; 41:441-447

2000

• Zerr, I., Schulz-Schaeffer, W.J., Giese, A., Bodemer, M., Schröter, A., Henkel, K., Tschampa, H., Windl, O., Pfahlberg, A., Steinhoff, B., Gefeller, O., Kretzschmar, H.A., Poser, S. Current clinical diagnosis of CJD: identification of uncommon variants. Ann Neurol 2000; 48: 323-329
• Zerr, I., Pocchiari, M., Collins, S., Brandel, J.P., de Pedro Cuesta, J., Knight, R., Bernheimer, H., Cardone, F., Delasnerie-Lauprêtre, N., Cuadrado-Corrales, N., Ladogana, A., Bodemer, M., Fletcher, A., Awan, T., Ruiz Bremon, A., Budka, H., Laplanche, J.L., Will, R.G., Poser, S. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55:811-815
• Zerr, I., Brandel, J.-P., Masullo, C., Wientjens, D.P.W.M., de Silva, R., Zeidler, M., Granieri, E., Sampaolo, S., van Duijn, C., Delasnerie-Lauprêtre, N., Will, R.G., Poser, S. European surveillance on Creutzfeldt-Jakob disease: A case-control study for medical risk factors. Journal of Clinical Epidemiology 2000; 53: 747-754
• Schröter, A., Zerr, I., Henkel, K., Tschampa, H., Finkenstaedt, M., Poser, S. Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol 2000; 57: 1751-1757
• Brown, P., Preece, M., Brandel, J.-P., Sato, T., McShane, L., Zerr, I., Fletcher, A., Will, R.G., Pocchiari, M., Cashman, N.R., d’Aignaux, J.H., Cervenákova, L., Fradkin, J., Schonberger, L.B., Collins, S.J. Iatrogenic Creutzfeldt-Jakob disease at the millenium. Neurology 2000; 55: 1075-1081
• Bieschke, J., Giese, A., Schulz-Schaeffer, W., Zerr, I., Poser, S., Eigen, M., Kretzschmar, H. A.: Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. PNAS 2000; 97:5468-5473
• Otto, M., Esselmann, H., Schulz-Schaeffer, W., Neumann, M., Schröter, A., Ratzka, P., Cepek, L., Zerr, I., Steinacker, P., Windl, O., Kornhuber, J., Kretzschmar, H.A., Poser, S., Wiltfang, J. Decreased levels of ß-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurology 2000; 54: 1099-1102
• Bleich, S., Kropp, S., Degner, D., Zerr, I., Pilz, J., Gleiter, C.H., Otto, M., Rüther, E., Kretzschmar, H.A., Wiltfang, J., Kornhuber, J., Poser, S. Creutzfeldt-Jakob disease and oxidative stress. Acta Neurol Scand 2000; 101: 332-334
• Zeidler, M., Green, A.J., Zerr, I. Case 28-1999: Creutzfeldt-Jakob disease. N Engl J Med 2000; 342: 292-293
• Kropp, S., Finkenstaedt, M., Zerr, I., Schröter, A., Poser, S. Diffusion-weighted MRI in patients with Creutzfeldt-Jakob disease. Nervenarzt 2000; 71: 91-95
• Kropp, S., Riedemann, C., Zerr, I., Schröter, A., Poser, S. Perspectives on medical research by relatives of patients with Creutzfeldt-Jakob disease. Psychiat Prax 2000; 27: 248-51

1999

• Alpérovitch, A., Zerr, I., Pocchiari, M., Mitrova, E., de Pedro Cuesta, J., Hegyi, I., Collins, S., Kretzschmar, H.A., van Duijn, C., Will, R.G. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 1999; 353: 1673-1674
• Wiltfang, J., Otto, M. Baxter H.C., Bodemer, M., Steinacker, P., Bahn, E., Zerr, I., Kornhuber, J., Kretzschmar, H.A., Poser, S., Aitken, A. Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurochem 1999; 73: 2485-2490
• Windl, O., Giese, A., Schulz-Schaeffer, W.J., Zerr, I., Skworc, K., Arendt, S., Oberdieck, C., Bodemer, M., Poser, S., Kretzschmar, H.A. Molecular genetics of human prion diseases in Germany. Hum Genet 1999; 105: 244-252
• Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W.J., Windl, O., Zerr, I., Budka, H., Kopp, N., Piccardo, P., Poser, S., Rojiani, A., Streichem-berger, N., Julien, J., Vital, C., Ghetti, B., Gambetti, P., Kretzschmar, H.A. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-233
• Poser, S., Mollenhauer, B., Kraus, A., Zerr, I., Steinhoff, B., Schröter, A., Finkenstaedt, M., Schulz-Schaeffer, W., Kretzschmar, H.A., Felgenhauer K. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 1999; 122: 2345-2351
• Laske, C., Gefeller, O., Pfahlberg, A., Zerr, I., Schröter, A., Kretzschmar, H.A., Poser, S. The effect of stress on the onset and progression of Creutzfeldt-Jakob disease: results of a German pilot case-control study. European Journal of Epidemiology 1999; 15:631-635
• Kropp, S., Zerr, I., Schulz-Schaeffer, W., Riedemann, Chr., Bodemer, M., Laske, C., Kretzschmar, H.A., Poser, S. Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease. Neuroscience Letters 1999; 261: 124-126
• Skworc, K., Windl, O., Schulz-Schaeffer, W.J., Giese, A., Bergk, J., Nägele, A., Vieregge, P., Zerr, I., Poser, S., Kretzschmar, H.A. Familial Creutzfeldt-Jakob disease with a novel 120-bp insertion in the prion protein gene. Ann Neurol 1999; 46(5): 693-700
• Seipelt, M., Zerr, I., Nau, R., Mollenhauer, B., Kropp, S., Steinhoff, B., Wilhelm-Gössling, C., Bamberg, Chr., Janzen, R.W.C., Berlit, P., Manz, F., Felgenhauer, K., Poser, S. Hashimoto encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. JNNP 1999; 66:172-176
• Kropp, S., Schulz-Schaeffer, W., Finkenstaedt, M, Riedemann, Chr., Windl. O., Steinhoff, B., Zerr, I., Kretzschmar, H.A., Poser, S. The „Heidenhain“ variant of Creutzfeldt-Jakob disease. Arch Neurology 1999; 56:55-61
• Marienhagen, J., Weingärtner, U., Zerr, I., Poser, S., Blaha, L., Eilles, C. Hirn-SPECT mit Tc-99m Bicisat (ECD) bei rasch progredientem dementiellemnSyndrom. Nuklearmedizin 1999; 38(6): 203-206
• Riedemann, Chr., Zerr, I., Kropp, S., Otto, A., Poser, S., Herrmann, C. Verlauf von Angst, Depressivität und Lebensqualität bei Angehörigen von Creutzfeldt-Jakob Kranken. Zsch Psychosom Med. 1999; 45:128-141

1998

• Otto, M., Zerr, I., Poser, S., Wiltfang, J., Schütz, E., Pfahlberg, A., Gefeller. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum. (letter) BMJ 1998; 317: 472-473.
• Kretzschmar, H.A., Giese, A., Zerr, I., Windl, O., Schulz-Schaeffer, W.J., Skworz, K., Poser, S. The German FFI cases. Brain Pathology 1998; 8: 559-561
• Zerr, I., Giese, A., Windl, O., Kropp, S., Schulz-Schaeffer, W.J., Riedemann, C., Skworc, K., Bodemer, M., Kretzschmar, H.A., Poser, S. Phenotypic variability in Fatal Familial Insomnia (D178-129M) genotype. Neurology 1998; 51: 1398-1404
• Zerr, I., Bodemer, M., Gefeller, O., Otto, M., Poser, S., Wiltfang, J., Windl, O., Kretzschmar, H.A., Weber, T. Detection of 14-3-3 protein in cerebrospinal fluid strongly supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43 (1): 32-40
• Will R.G., Alpérovitch, A., Poser, S., Pocchiari, M., Hofman, A., Mitrova, E., de Silva, R., D`Alessandro, M., Brandel, J.-P., Zerr, I., van Duijn, C. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. Ann Neurol 1998; 43(6):763-767
• van Duijn C., Delasnerie-Laupretre, N., Masullo, C., Zerr, I., de Silva, R., Wientjens, D.P.W.M., Brandel, J.-P., Weber, T., Almonti, S., Zeidler, M., Alpérovitch, A., Poser, S., Granieri, E., Hofman, A., Will, R.G. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-1995. Lancet 1998; 351:1081-1085.
• Otto, A., Zerr, I., Lantsch, M., Weidehaas, K., Riedemann, Chr., Poser, S. Akinetic mutism as a classification criterion for the diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosur Psychiatry 1998; 64(4): 524-528
• Otto, M., Wiltfang, J., Schütz, E., Zerr, I., Otto, A., Pfahlberg, A., Gefeller, O., Uhr, M., Giese, A., Weber, T., Kretzschmar, H.A., Poser, S. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum. BMJ 1998; 316 (7131): 577-582
• Kropp, S., Riedemann, C., Zerr, I., Poser, S. Wollen Angehörige von Creutzfeldt-Jakob Patienten genetisch aufgeklärt werden? DMW 1998; 123 (34/35): 1023-1024
• Steinhoff, B., Herrendorf, G., Zerr, I., Poser, S. Creutzfeldt-Jakob disease. A sphinx of modern neurobiology. DMW 1998; 123 (6):169

1997

• Otto, M., Stein, H., Szudra, A., Zerr, I., Bodemer, M., Gefeller, O., Schulz-Schäfer, W.J., Kretzschmar, H.A., Mäder, W., Poser, S., Weber, T. S100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol 1997; 244: 566-570
• Zerr, I., Bodemer, M., Weber, T. The 14-3-3 brain protein and transmissible spongiform encephalopathy. N Engl J Med 1997; 336: 874
• Otto, M., Wiltfang, J., Tumani, H., Zerr, I., Lantsch, M., Kornhuber, J., Weber, T., Kretzschmar, H.A., Poser, S. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neuroscience Letters 1997; 225: 210-212
• Poser, S., Zerr, I., Schulz-Schaeffer, W.J., Kretzschmar, H.A., Felgenhauer, K. The Creutzfeldt-Jakob disease. A sphinx of current neurobiology. DMW 1997; 122: 1099-1105

1996

• Zerr, I., Helmhold, M., Poser, S., Armstrong, V. W., Weber, T. Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt-Jakob disease. Arch Neurol 1996; 53: 1233-1238
• Zerr, I., Bodemer, M., Otto, M., Poser, S., Windl, O., Kretzschmar, H.A., Gefeller, O., Weber, T. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet 1996; 348: 846-849
• Steinhoff, B. J., Racker, S., Herrendorf, G., Poser, S., Grosche, S., Zerr, I., Kretzschmar, H.A., Weber, T. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996; 53: 162-166
• Finkenstaedt, M., Szudra, A., Zerr, I., Poser, S., Hise, J. H., Stoebner, J. M., Weber, T. MR imaging of Creutzfeldt-Jakob disease. Radiology 1996; 199:793-798
• Poser, S., Weber, T., Zerr, I., Giese, A., Gefeller, O., Felgenhauer, K., Kretzschmar, H. Keine Häufung der Creutzfeldt-Jakob-Krankheit in der Bundesrepublik Deutschland. Dt Ärztebl 1996; 93: A-2149-2150

1995

• Zerr, I., Bodemer, M., Räcker, S., Grosche, S., Poser, S., Kretzschmar, H. A., Weber, T. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995; 345: 1609-1610
• Zerr, I., Helmhold, M., Weber, T., Armstrong, VW. Apolipoprotein E in Creutzfeldt-Jakob disease. Lancet 1995; 345: 68-69
• Bogumil T., Jacobsen, Th., Windl, O., Giese, A., Beuche, W., Zerr, I., Räcker, S., Grosche, S., Szudra, A., Poser, S., Weber, T., Kretzschmar, H.A. Cerebellar changes in sporadic Creutzfeldt-Jakob disease: a synopsis of clinical, histological, immunohistochemical and genetic data. E J Pathol 1995; 1:3
• Krasemann, S., Zerr, I., Weber, T., Poser, S., Kretzschmar, H. A., Hunsmann, G., Bodemer, W. Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene. Molecular Brain Research 1995; 34: 173-176
• Noch, S., Zerr, I., Poser, S., Hunsmann, G., Bodemer, W. A novel insertion mutant comprising nine extra octapeptide repeats within the human prion gene. Med Genetik 1995; 2: 266-267

Übersichtsarbeiten

• Heinemann U, Gawineck,a J, Schmidt C, Zerr I. Differential Diagnosis of rapid progressive dementia. European Neurological Review, 2010; 5(2): 21-8
• Schelzke G, Zerr I. Update Prionerkrankungen. Der Neurologe und Psychiater. 2010, 9: 45-52
• Gawinecka J, Zerr I. Cerebrospinal fuid biomarkers in human prion diseases. Future Neurol 2010; 5(2): 301-16
• Gloeckner F, Zerr I. Transthyretin cerebospinal fluid levels in Alzheimer’s disease – Is this a biomarker for disease severity? Touch briefings. US Neurology 2009; 5(1): 18-20
• Kittner, C., Heinemann, U., Zerr, I. Risk factors for sporadic Creutzfeldz-Jakob disease Risikofaktoren der sporadischen Creutzfeldt-Jakob Krankheit. DMW 2009; 134: 1429-34
• Zerr, I. Therapeutic trials in human transmissible songiform encephalopathies: recent advances and problems to address. Infectious Disorders - Drug Targets 2009, 9 (1):92-9.
• Zerr, I. Creutzfeldt-Jakob Erkrankung: Phänomenologie und therapeutsche Ansätze. Ärztliche Praxis Neurologie/Psychiatrie, 2008, 5: 44-49.
• Heinemann, U., Weiss, S., Zerr, I. Therapeutic approaches for treatment of Creutzfeldt-Jakob disease. Med Monatsschr Pharm, 2008, 10:378-384
• Ludewigs, H., Zuber, Ch., Vana, K., Nikles, D., Zerr, I., Weiss, S.Therapeutic approaches for prion disorders.Expert Review of Anti-infective Therapy. 2007, 5(4): 613-630
• Heinemann, U., Zerr, I. Demenzen: Pathogenese, neurochemische Diagnostik sowie reversible Demenzsyndrome. Neuroforum, 2007, 2: 47-54
• Heinemann, U., Weih, M., Wiltfang J., Zerr I. Früh beginnende und rasch verlaufende Demenzen. Psychiatrie und Psychotherapie up2date. 2007, 1: 321-336
• Heinemann, U., Gloeckner, F., Varges, D., Meissner, B., Krasnianski, A., Zerr. I. Differentialdiagnose rasch progredienter Demenzen. Zeitschrift für Gerontopsychologie und-psychiatrie. 2007, 20 (1), 17-26
• Von Auer, F., Burger, R., Buschmann, A., Dietz, K., Heiden, M., Hitzler, WE, Klamm, H., Kreil, T., Kretszchmar, HA, Nübling, M., Offergeld, R., Pauli, G., Schottstedt, V., Seitz, R., Volkers, P., Zerr, I. Overall blood supply strategy with regard to Variant Creutzfeldt-Jakob disease (VCJD). Report of the Working group Commissioned by the German Federal Ministry of Health. Transfusion Medicine and Hemotherapy. 2006, Vol. 33, Suppl. 2
• Krasnianski, A., Meissner, B., Heinemann, U., Zerr, I. Clinical findings and diagnostic tests in CJD and vCJD. Folia Neuropathol 2006; 42:24-38.
• Blümel, J., Burger, R., Gerlich, W., Gürtler, L., Heiden, M., Hitzler, W., Jansen, B., Klamm, H., Ludwig, W-D., Montag-Lessig, T., Offergeld, R., Paessens, A., Pauli, G., Seitz, R., Schlenkrich, U., Schottstedt, V., Willkommen, H., Beekes, M., Zerr, I. (AK Blut des BMGS). Variante Creutzfeldt-Jakob-Krankheit. Budesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2005;48 (9): 1082-90.
• Blumel, J., Burger, R., Gerlich, W., Gurtler, L., Heiden, M., Hitzler, W., Jansen, B., Klamm, H., Ludwig, W. D., Montag-Lessing, T., Offergeld, R., Paessens, A., Pauli, G., Seitz, R., Schlenkrich, U. Schottstedt, V., Willkommen, H., Beekes, M., Zerr, I. Variant Creutzfeldt-Jakob disease. Transfusion Medicine and Hemotherapy 2005; 32: 227-236.
• Poser, S., Bartl. M., Jastrow, U., Körtner, K., Molelnhauer, B., Schneider-Dominco, M. , Zerr, I. Prion induced diseases. Transplantationsmedizin 2003, 15 (1):60-63
• Zerr, I. Die Creutzfeldt-Jakob-Krankheit, deren Variante und klinische Diagnose. Die Medizinische Welt; 2003, 54/11: 293-299.
• Zerr I, Poser S. Creutzfeldt-Jakob Krankheit: Zusammenspiel von Genetik und Umweltfaktoren. Neuroforum 2003,
• Zerr I., Poser S. Diagnostik und Klinik der CJK. Der Kassenarzt 2003; 16: 26-29
• Zerr, I., Poser, S. Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests. APMIS 2002; 110(1): 88-98.
• Poser, S., Zerr, I. Klinik, Diagnostik und Therapiemöglichkeiten der menschlichen Prionerkrankungen. Internist 2002; 43: 731-737
• Poser, S., Zerr, I., Felgenhauer, K. Die neue Variante der Creutzfeldt-Jakob-Krankheit. DMW 2002; 127(7): 331-334
• Zerr, I., Mollenhauer, B., Werner, C., Poser, S. Früh- und Differentialdiagnose der Creutzfeldt-Jakob-Krankheit. DMW 2002; 127(7): 323-327
• v. Rheinbaben, F., Appel, T., Zerr, I. Spongiforme Enzephalopathien: Zum Umgang mit Creutzfeldt-Jakob Patienten. Endo-Praxis 2000; 16 (2): 6-12
• Poser, S., Zerr, I., Schröter, A., Otto, M., Giese, A., Steinhoff, B.J., Kretzschmar H.A. Clinical and differential diagnosis of Creutzfeldt-Jakob disease. Arch Virol 2000; (Suppl) 16: 153-159
• Otto, M., Zerr, I., Wiltfang, J., Weber, T., Kretzschmar, H.A., Poser, S., Felgenhauer, K. Laborchemische Verfahren in der Differentialdiagnose der Creutzfeldt-Jakob-Krankheit. Dt Ärtztebl 1999; 96: A-3097-3102 (Heft 48)
• Riedemann, Chr., Giese, A., Kropp, S., Zerr, I., Schulz-Schaeffer, W., Poser, S., Kretzschmar, H.A. Die Creutzfeldt-Jakob Krankheit. MTA 1998; 13 (11): 796-804
• Weber, T., Otto, M., Bodemer, M., Zerr, I. Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies. Biomed Pharmacotherapy 1997; 51 (9): 381-387
• Zerr, I., Otto, A., Riedemann, C., Poser, S. Neue Variante der Creutzfeldt-Jakob Krankheit. Ätiologie und klinische Besonderheiten. Zeitschrift für Allgemeinmedizin 1997; 73:507-511
• Poser S., Zerr, I., Weidehaas, K. Epidemiological and clinical features of Creutzfeldt-Jakob disease (CJD). Biotest Bulletin 1997; 5: 359-361
• Weber, T., Zerr, I., Bodemer, M., Poser, S. Expanded illness spectrum of human spongiform encephalopathies or prion diseases. Nervenarzt 1997; 68(4): 309-323.

Buchbeiträge

• Zerr I, Kaerst L, Gawinecka J, Verges D. Cerebrospinal fluid based diagnosis in Alzheimer's disease. In: The clinical Spectrum of Alzheimer's disease - The charge toward comprehensive diagnostic and therapeutic strategies, ISBN 978-953-307-993-6, edited by Suzanne De La Monte 2011, 207-220.
• Schmidt Ch., Wolff M, Shalash A and Zerr I. Risk Factors for disease progression in Alzheimer's Disease. In: The Clinical Sprectrum of Alzheimer's Disease - the charge toward comprehensive diagnostic and therapeutic strategies, ISBN 978-953-307-993-6, edited by Suzanne De La Monte 2011, 3-20.
• Sikorska, B., Zerr, I., Grams, R., Caughey, B., Golanska, E., Bartosiewicz-Wasik, J., Liberski, P. Nowy wariant choroby Creutzfeldta-Jakoba i choroby wywolane przez prionys-problem globalnego zagrozenia. (A new variant of Creutzfeldt-Jakob diseases and prion diseases - a problem of global risk). In: J. Leszka, Choroby o tepienne. Teoria I praktyka, S. 157-199. Continuo, Wroclaw, 2011, ISBN 978-83-62182-03-9.
• Zerr I. Prion diseases. Brenner’s Online Encyclopedia of Genetics 2nd Edition in press
• Chr. Schmidt, I. Zerr. Wernicke Encephalopathy. Cases Studies in Dementia: Common and Uncommon Causes. Ed: Serge Gauthier and Pedro Rosa-Nerto. Cambridge University Press, 2011: 172-179, ISBN 978-0-521-18830-2
• Zerr, I. Prionerkrankungen. In Berlit (Hrsg): Klinische Neurologie. Springer, 3. Auflage 2011, 778-784, ISBN 978-3-642-16919-9
• Liberski, P., Bratosiewicz-Wasik, J., Grams, A., Zerr,I., Sobow, T. Choroby wywolane przez priony. In: Psychiatria, Ed. Puzynski, Rybakowski, Wciorna. Elsevier, Wroslaw, 2011: 671-688, ISBN 978-83-7609-106-8
• Rodenbeck, A., Cohrs, S., Zerr, I. Letale Familiäre Insomnie (Fatal Familial Insomnia, FFI). In: S. Happe, B.W.Waltzer (Hrsg.): Schlafmedizin in der Praxis. Ecomed Medizin, 2009, 355-360 2009 Ecomed MEDIZIN ISBN 978-3-609-16406-9
• Zerr, I., Bähr, M. Human transmissible spongiform encephalopathies. in: Lang F. (Hrsg.): Encyclopedic Reference of Molecular Mechanisms of Disease. Springer-Verlag, 2009 in press
• Zerr, I. Clinical and therapeutic aspects of prion disease, in: C. Duyckaerts, I. Litvan (Hrsg.): Dementias 1, Handbook of Clinical Neurology series, 3rd Edition. Elsevier Limited, Edinburgh 2008 Vol 89: 737-764.
• Zerr, I., Budka, H., Sturzenegger, M., Steinhoff, B. J., Urbach, H., Kallenberg, K, Schulz, J. B., Creutzfeldt-Jakob-Krankheit, in: H. C. Diener, für die Kommission „Leitlinien" der Deutschen Gesellschaft für Neurologie (Hrsg.): Leitlinien für Diagnostik und Therapie in der Neurologie. 4., überarbeitete Auflage. Thieme, Stuttgart, 2008: 469-474
• Zerr, I. Methods for the Clinial Diagnosis of Human Prion Diseases. in: B. Hörnlimann, D. Riesner, H. A. Kretzschmar (Hrsg.): Prions and Prion Diseases. Walter de Gruyter, Berlin, New York 2006: 363-381
• Zerr, I., Poser, S. Epidemiology and Risk Factors of Creutzfeldt-Jakob Disease. in: B. Hörnlimann, D. Riesner, H. A. Kretzschmar (Hrsg.): Prions and Prion Diseases. Walter de Gruyter, Berlin, New York 2006 :423-432
• Zerr, I., Poser, S., Kretzschmar, H. A.: Creutzfeldt-Jakob disease in Germany, in: B. Hörnlimann, D. Riesner, H. A. Kretzschmar (Hrsg.): Prions and Prion Diseases. Walter de Gruyter, Berlin, New York 2006: 433-439
• Boesenberg-Grosse, C., Schulz-Schaeffer, W.J., Zerr, I. Brain-derived proteins in the cerebrospinal fluid and neuropathological lesion profiles in CJD. In: Alzheimer’s Disease: New Advances. Ed. Iqbal, K., Winblad, B., Avila, J. Medimont International Proceedings. 2006; 115-120.
• Poser, S., Zerr, I. Möglichkeiten und Bedeutung neurobiochemischer Diagnostik, in: Wallesch (Hrsg.): Neurologie – Diagnostik und Therapie in Klinik und Praxis. 1. Auflage. Urban & Fischer, München, 2005.
• Zerr, I., Janzen, R. W. C., Schulz, J. B., Steinhoff, B. J., Urbach, H.: Creutzfeldt-Jakob-Krankheit, in: H. C. Diener, für die Kommission „Leitlinien" der Deutschen Gesellschaft für Neurologie (Hrsg.): Leitlinien für Diagnostik und Therapie in der Neurologie. 3., überarbeitete Auflage. Thieme, Stuttgart, 2005: 317-322.
• Zerr, I. Klinische Diagnose und Epidemiologie der Creutzfeldt-Jakob-Krankheit. In: Fortschritt und Fortbildung in der Medizin. Bundesärztekammer, Band 27 (2003/2004). S. 40-46
• Zerr, I., Poser, S. Epidemiology and risk factors of transmissible spongiform encephalopathies (TSE) in man. in: H. F. Rabenau, J. Cinatl, Doerr, H. W. (Hrsg.): Prions. A challenge for science, medicine and public health system. Contributions to microbiology. S. Karger AG, Basel, 2004;11:98-116.
• Zerr, I.,Schulz-Schaeffer, W. Neue Variante der Creutzfeldt-Jakob-Krankheit, in: Henkes, Kölmel (Hrsg.):“Die entzündlichen Erkrankungen des Zentralnervensystems“. Ecomed Verlagsgesellschaft AG, Landsberg, 2003
• Zerr, I.: Der Beitrag von Liquoruntersuchungen zur Frühdiagnose der Creutzfeldt-Jakob-Erkrankung, Shaker Verlag, Aachen, 2003
• Zerr, I., Janzen, R. W. C., Schulz, J. B., Steinhoff, B. J., Urbach, H.: Creutzfeldt-Jakob-Krankheit, in: H. C. Diener, für die Kommission „Leitlinien" der Deutschen Gesellschaft für Neurologie (Hrsg.): Leitlinien für Diagnostik und Therapie in der Neurologie. 2., überarbeitete Auflage. Thieme, Stuttgart, 2003: 216-219
• Zerr, I. Differentialdiagnostik präseniler Demenzen. Sonderband Aktuelle Neurologie, Fortbildungsband der 75. Jahrestagung der Deutschen Gesellschaft für Neurologie. Thieme 2002, Herausgeber: W. Hacke, M. Hennerici, H.C. Diener, K. Felgenhauer, C.W. Wallesch, E. Busch, S. 460-462
• Zerr, I. Epidemiologie der Prionenerkrankungen". Sonderband Aktuelle Neurologie, Fortbildungsband der 75. Jahrestagung der Deutschen Gesellschaft für Neurologie. Thieme 2002, Herausgeber: W. Hacke, M. Hennerici, H.C. Diener, K. Felgenhauer, C.W. Wallesch, E. Busch, S.
• Zerr, I., Janzen, R. W. C., Schulz, J. B., Steinhoff, B. J., Urbach, H.: Creutzfeldt-Jakob-Krankheit, in: H. C. Diener und W. Hacke, für die Kommission „Leitlinien" der Deutschen Gesellschaft für Neurologie (Hrsg.): Leitlinien für Diagnostik und Therapie in der Neurologie. 1. Auflage. Thieme, Stuttgart, 2002: 38-41
• Zerr, I. Phänotypische Charakteristika der sporadischen Creutzfeldt-Jakob Krankheit. Sonderband Aktuelle Neurologie, Fortbildungsband der 74. Jahrestagung der Deutschen Gesellschaft für Neurologie. Thieme 2001, Herausgeber: J. Noth, H.C. Diener, K. Felgenhauer, C.W. Wallesch, E. Busch, S. 521-523
• Zerr, I. und Poser, S.: Epidemiology and risk factors of transmissible spongiform encephalopathies in man, in: H. F. Rabenau, J. Cinatl, Doerr, H. W. (Hrsg.): Prions. A challenge for science, medicine and public health system. Contributions to microbiology. S. Karger AG, Basel, 2001, 7: 93-104
• Zerr, I. und Poser, S.: Die klinischen Diagnostikmethoden bei Prionkrankheiten des Menschen, in: B. Hörnlimann, D. Riesner, H. A. Kretzschmar (Hrsg.): Prionen und Prionkrankheiten. Walter de Gruyter, Berlin, New York 2001: 261-271
• Zerr, I. und Poser, S.: Die Epidemiologie und Risikofaktoren der Creutzfeldt-Jakob-Krankheit, in: B. Hörnlimann, D. Riesner, H. A. Kretzschmar (Hrsg.): Prionen und Prionkrankheiten. Walter de Gruyter, Berlin, New York 2001: 299-305
• Zerr, I., Gefeller, O., Kretzschmar, H. A. und Poser, S.: Die epidemiologische Erfassung der Prionkrankheiten des Menschen, in: B. Hörnlimann, D. Riesner, H. A. Kretzschmar (Hrsg.): Prionen und Prionkrankheiten. Walter de Gruyter, Berlin, New York 2001: 306-311
• Zerr, I. Übertragbare Spongiforme Enzephalopathien (Prionerkrankungen). B7-1 - 8. Aktuelle Neurologie, Fortbildungsband der 72. Jahrestagung der Deutschen Gesellschaft für Neurologie. Thieme 1999, Herausgeber: C.W. Wallesch, H.C. Diener, K. Felgenhauer, F. Wiegand
• Zerr, I., Gefeller, O., Otto, A., Riedemann, Chr., Bodemer, M., Poser, S. Epidemiologische Untersuchungen der Creutzfeldt-Jakob Erkrankung in der Bundesrepublik Deutschland In: R. Muche, G. Büchele, D. Harder, W. Gaus (Eds.): Medizinische Informatik, Biometrie und Epidemiologie. 42. Jahrestagung der Deutschen Gesellschaft für Informatik, Biometrie und Epidemiologie (GMDS), Ulm, September 1997, MMV Medizin Verlag, München:450-454